A Study to Evaluate ICU Simulation Experience in the Cardiothoracic Surgical Population to Reduce Post-operative Delirium

March 24, 2025 updated by: Robert (Bobby) J. Anderson, Mayo Clinic

Pre-operative, Multi-sensory ICU Simulation Experience to Reduce Post-operative Delirium in the Cardiothoracic Surgical Population

The purpose of this study is to evaluate the effect of a pre-ICU admission virtual reality ICU simulation on post-operative delirium in the elective cardiothoracic surgical population while in the intensive care unit.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

234

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minnesota
      • Rochester, Minnesota, United States, 55905
        • Mayo Clinic in Rochester

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients with normal neurologic function scheduled for elective cardiothoracic surgery.

Description

Inclusion Criteria:

  • Baseline normal neurological function pre-operatively.
  • Planned use of mechanical ventilator with endotracheal tube post-operatively after planned cardiothoracic surgical procedure.

Exclusion Criteria:

  • Chronic dementia, Alzheimer's disease, or other chronic neurological disease (i.e., Bi-Polar).
  • Chronic use of neurological altering medications such as benzodiazepines, psychotropic, anti-depressants, anxiolytics.
  • Patient undergoing emergent surgery.
  • Use of post-operative cardiopulmonary support devices such as ECMO (extracorporeal membrane oxygenation), intra-aortic balloon pump, total artificial heart, or other similar device.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Confusion Assessment Method for the ICU (CAM-ICU)
Time Frame: Once, during ICU admission within 24 hours of ICU admission.
Number of Participants with one or more Positive Confusion Assessment. "Confusion Assessment Method for the ICU" - Establishes ability to detect delirium in high-risk settings such as the intensive care unit. Recorded during every scheduled patient assessment by nurse and with mental changes. Reports as "Positive" or "Negative" with response to different assessments regarding level of consciousness, acute onset or fluctuating course of mental status and inattention.
Once, during ICU admission within 24 hours of ICU admission.
Subjective Experiential Outcome After ICU Simulation
Time Frame: Once, immediately following the virtual reality ICU simulation session.
Survey questions to understand patient's subjective experience during the virtual reality ICU simulation session. Internally created survey. The number of subjects who completed the survey.
Once, immediately following the virtual reality ICU simulation session.
Subjective Experiential Outcome After ICU Admission
Time Frame: Once, up to 3 days after transfer out of the Intensive Care Unit.
Survey questions to understand patient's subjective experience in the intensive care unit. The number of subjects who completed the survey.
Once, up to 3 days after transfer out of the Intensive Care Unit.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration of ICU Admission
Time Frame: During ICU admission; average 2 days
Number of hours in the intensive care unit measured in the electronic health record from admission time to the ICU to discharge time from the ICU.
During ICU admission; average 2 days
Duration of Intravenous Sedation in the ICU
Time Frame: During ICU admission; average 2 days
Number of hours of intravenous sedation in the ICU measured through the medication administration record via the electronic healthcare record.
During ICU admission; average 2 days
Duration of Mechanical Ventilation in the ICU
Time Frame: During ICU admission; average 2 days
Number of hours of mechanical ventilation in the ICU measured via the electronic healthcare record with data imported into the electronic healthcare record directly from the mechanical ventilator.
During ICU admission; average 2 days
Use of Anti-psychotic Medications
Time Frame: Throughout ICU admission; average of 5 days
Number of antipsychotic medication administrations in the ICU measured through the medication administration record via the electronic healthcare record.
Throughout ICU admission; average of 5 days
Cardiopulmonary Bypass
Time Frame: During OR case; average 12 hours
Number of hours of use of cardiopulmonary bypass in the operating room via record from the cardiopulmonary bypass perfusionist in the operating room imported into the electronic healthcare record.
During OR case; average 12 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Robert Anderson, APRN, CNP, DNP, Mayo Clinic

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 2, 2021

Primary Completion (Actual)

June 1, 2022

Study Completion (Actual)

August 20, 2023

Study Registration Dates

First Submitted

October 13, 2021

First Submitted That Met QC Criteria

December 10, 2021

First Posted (Actual)

December 16, 2021

Study Record Updates

Last Update Posted (Actual)

April 8, 2025

Last Update Submitted That Met QC Criteria

March 24, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post-Operative Delirium

Subscribe